Results 221 to 230 of about 966,197 (400)

Renal and Cardiovascular Effects of Atrial Natriuretic Peptide in Fetal Sheep [PDF]

, 1989
Barbara Hargrave, Harriet S. Iwamoto, Abraham M. Rudolph   +2 more
openalex   +1 more source

eGFR slope as predictor of mortality in heart failure patients

ESC Heart Failure, Volume 12, Issue 2, Page 1217-1226, April 2025.
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward Heggermont, Jeroen Dauw, Dries Hens, Jozef Bartunek, Marc Vanderheyden   +10 more
wiley   +1 more source

Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype. [PDF]

Front Immunol
Horváth D, Pénzes Z, Molnár P, Rebenku I, Vereb G, Szántó M, Muzsai S, Szegedi A, Dajnoki Z, Pázmándi K, Fekete T, Bácsi A, Szöllősi AG.   +12 more
europepmc   +1 more source

Dose-Dependent Effect of Atrial Natriuretic Peptide on Blood Pressure, Heart Rate, and Skin Blood Flow of Normal Volunteers

, 1986
J. P. Bussien, Jérôme Biollaz, Bernard Waeber, J. Nussberger, G. A. Turini, Hans R. Brunner, Françoise Brunner‐Ferber, Héctor W. Gómez, E S Otterbein   +8 more
openalex   +1 more source

Plasma acidification increases atrial natriuretic peptide as measured by radioimmunoassay. [PDF]

, 1987
M. G. Buckley, Giuseppe A. Sagnella, Graham A. MacGregor   +2 more
openalex   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

ESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch, Ali Zafari, Shofiqul Islam, Shun Fu Lee, Rajiv Sankaranarayanan, Stephen J Greene, Mamas A Mamas, Ambarish Pandey, Harriette GC Van Spall   +8 more
wiley   +1 more source

Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients. [PDF]

Ren Fail
Matsumoto Y, Mori Y, Kageyama S, Yoshimura K, Saito T, Terada R, Nojima Y.   +6 more
europepmc   +1 more source

From Snake Venoms to Therapeutics: A Focus on Natriuretic Peptides. [PDF]

Pharmaceuticals (Basel), 2022
Ang WF, Koh CY, Kini RM.
europepmc   +1 more source

BglII dimorphism at the human atrial natriuretic peptide (ANP) gene locus [PDF]

, 1986
P.M. Frossard, Patricia González, Barry Greenberg, John C. Fiddes, Steven A. Atlas   +4 more
openalex   +1 more source

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

ESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul, Robert J. Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan Voors, Stefano Corda, Ciaran McMullan, Christopher M. O'Connor, Kevin J. Anstrom, Paul W. Armstrong, for the VICTORIA Study Group   +13 more
wiley   +1 more source